CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Return
34.55%
This Quarter Return
-2.01%
1 Year Return
+34.55%
3 Year Return
+41.71%
5 Year Return
+124.92%
10 Year Return
+254.42%
AUM
$98B
AUM Growth
-$2.43B
(-2.4%)
Cap. Flow
-$1.02B
Cap. Flow
% of AUM
-1.05%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,235
New
68
Increased
954
Reduced
1,920
Closed
79
Top Buys
| 1 |
iShares MSCI Global Min Vol Factor ETF
ACWV
|
+$579M |
| 2 |
CRH
CRH
|
+$101M |
| 3 |
Alibaba
BABA
|
+$100M |
| 4 |
Amazon
AMZN
|
+$97M |
| 5 |
Apple
AAPL
|
+$91.6M |
Top Sells
| 1 |
UBS Group
UBS
|
+$330M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$308M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$267M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$204M |
| 5 |
Mercado Libre
MELI
|
+$182M |
Sector Composition
| 1 | Technology | 25.3% |
| 2 | Healthcare | 15.06% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 10.02% |
| 5 | Industrials | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Park National Corp
PRK
$2.7B
| $1.4M | ﹤0.01% |
14,801
-934
| -6% | -$88.3K |
|
|
NVEI
2002
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $1.4M | ﹤0.01% |
93,251
-14,774
| -14% | -$222K |
|
2003
Supernus Pharmaceuticals
SUPN
$2.57B
| $1.4M | ﹤0.01% |
50,692
-2,906
| -5% | -$80.1K |
|
|
STR
2004
DELISTED
Sitio Royalties
STR
| $1.4M | ﹤0.01% |
57,717
-28,401
| -33% | -$688K |
|
2005
Harmonic Inc
HLIT
$1.12B
| $1.4M | ﹤0.01% |
145,004
+2,789
| +2% | +$26.9K |
|
2006
Uranium Energy
UEC
$5.24B
| $1.39M | ﹤0.01% |
270,864
+2,419
| +0.9% | +$12.5K |
|
2007
Geron
GERN
$836M
| $1.39M | ﹤0.01% |
656,570
-44,343
| -6% | -$94K |
|
2008
Wabash National
WNC
$458M
| $1.39M | ﹤0.01% |
65,828
-2,594
| -4% | -$54.8K |
|
2009
MGP Ingredients
MGPI
$593M
| $1.39M | ﹤0.01% |
13,175
-1,026
| -7% | -$108K |
|
2010
Clearwater Analytics
CWAN
$5.77B
| $1.39M | ﹤0.01% |
71,845
-159
| -0.2% | -$3.08K |
|
2011
Enovix
ENVX
$1.74B
| $1.39M | ﹤0.01% |
126,511
-3,839
| -3% | -$42.2K |
|
|
ARR
2012
Armour Residential REIT
ARR
$1.72B
| $1.39M | ﹤0.01% |
65,307
+1,205
| +2% | +$25.6K |
|
2013
Marcus & Millichap
MMI
$1.27B
| $1.39M | ﹤0.01% |
47,284
-1,437
| -3% | -$42.2K |
|
2014
Simulations Plus
SLP
$290M
| $1.39M | ﹤0.01% |
33,241
-797
| -2% | -$33.2K |
|
2015
Provident Financial Services
PFS
$2.59B
| $1.38M | ﹤0.01% |
90,463
-3,593
| -4% | -$54.9K |
|
2016
Oxford Industries
OXM
$704M
| $1.38M | ﹤0.01% |
14,355
-823
| -5% | -$79.1K |
|
2017
AdvanSix
ASIX
$581M
| $1.38M | ﹤0.01% |
44,310
+290
| +0.7% | +$9.01K |
|
2018
GDS Holdings
GDS
$7.22B
| $1.37M | ﹤0.01% |
125,403
-374,003
| -75% | -$4.1M |
|
2019
First Majestic Silver
AG
$5.2B
| $1.37M | ﹤0.01% |
267,668
-9,760
| -4% | -$50.1K |
|
|
PLL
2020
DELISTED
Piedmont Lithium
PLL
| $1.36M | ﹤0.01% |
34,342
+1,943
| +6% | +$77.1K |
|
2021
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $1.36M | ﹤0.01% |
364,506
-17,851
| -5% | -$66.8K |
|
2022
Veritex Holdings
VBTX
$1.88B
| $1.36M | ﹤0.01% |
75,889
-2,555
| -3% | -$45.9K |
|
2023
US Physical Therapy
USPH
$1.24B
| $1.36M | ﹤0.01% |
14,849
+395
| +3% | +$36.2K |
|
2024
Cross Country Healthcare
CCRN
$408M
| $1.36M | ﹤0.01% |
54,842
-1,646
| -3% | -$40.8K |
|
2025
TETRA Technologies
TTI
$634M
| $1.36M | ﹤0.01% |
212,745
-44,021
| -17% | -$281K |
|